Trial Profile
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled, Adaptive Study of the Safety and Efficacy of RDC-0313 in Adults With Alcohol Dependence
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Oct 2019
Price :
$35
*
At a glance
- Drugs Samidorphan (Primary)
- Indications Alcoholism
- Focus Therapeutic Use
- Sponsors Alkermes
- 29 Oct 2014 New trial record